Article

South China Morning PostSouth China Morning Post on 2020-02-03 10:04

China starts clinical trials for new antiviral drug to treat coronavirus

Remdesivir, developed by Gilead Sciences, was last week given to US patient whose condition appeared to improve within a day.

Related news